11.01.2017 21:13:00

Drug Eluting Stents Market Analysis & Trends- Product (Polymer-based Coatings, Non biodegradable Polymers, Nanoporous Surface and Polymer free Coatings)and Drugs Used (Anti-neoplastics,...

NEW YORK, Jan. 11, 2017 /PRNewswire/ -- The Global Drug Eluting Stents Market is poised to grow at a CAGR of around 3.8% over the next decade to reach approximately $9.45 billion by 2025. Some of the prominent trends that the market is Recent advancement in new generation DES with more biocompatible durable polymers, Proliferation of Drug Eluting Stents for Malignant Airway Obstruction, DES with inorganic coatings or porous surfaces are likely to promote enhanced endothelialisation and Growth Opportunities/Investment Opportunities.
Based on Product the market is categorized into Polymer-based Coatings and Polymer free Coatings. The Polymer-based Coatings segment is further divided as Biodegradable Polymers and Non biodegradable Polymers. Polymer free Coatings segment is further represented as Micro structured Surface, Micro porous Surface, Nanoporous Surface and Slotted Tubular Surface.
Based on Application the market is categorized into Coronary Artery Disease and Peripheral Artery Disease.
The Drugs Used segment market is classified as Anti-neoplastics, Immunosupressives, Migration Inhibitors and Enhanced Healing Factors.

This industry report analyzes the global markets for Drug Eluting Stents across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

The Drug Eluting Stents Market report provides data tables, includes charts and graphs for visual analysis.

Regional Analysis:
North America
- US
- Canada
- Mexico

Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe

Asia Pacific
- China
- Japan
- India
- Australia
- New Zealand
- Rest of Asia

Middle East
- Saudi Arabia
- UAE
- Rest of Middle East

Latin America
- Argentina
- Brazil
- Rest of Latin America

Rest of the World
-Africa
-Caribbean

Report Highlights:
- The report provides a detailed analysis on current and future market trends to identify the investment opportunities
- Market forecasts till 2025, using estimated market values as the base numbers
- Key market trends across the business segments, Regions and Countries
- Key developments and strategies observed in the market
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2025
- Market opportunities and recommendations for new investments

Read the full report: http://www.reportlinker.com/p04311520-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/drug-eluting-stents-market-analysis--trends--product-polymer-based-coatings-non-biodegradable-polymers-nanoporous-surface-and-polymer-free-coatingsand-drugs-used-anti-neoplastics-immunosupressives-and-enhanced-healing-facto-300389681.html

SOURCE Reportlinker

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!